Very encouraging results for disease progression from its phase II study! Hopefully this pans out with the phase II/III which they are now enrolling.
http://biz.yahoo.com/cnw/060307/bioms_s ... .html?.v=1
BioMS Medical's MBP8298 shows five-year delay of disease progression in patients with multiple sclerosis
Tuesday March 7, 8:55 am ET
-Results to be presented at the American Academy of Neurology April 4, 2006-
Toronto Stock Exchange Symbol: MS